VVP
NVO

Venture Visionary Partners’s Novo Nordisk NVO Stock Holding History

Venture Visionary Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$915K Sell
24,147
-548
-2% -$25.3K 0.02% 371
2026
Q2 		$1.18M Sell
24,695
-6,552
-21% -$282K 0.03% 319
2026
Q1 		$1.15M Buy
31,247
+15,651
+100% +$742K 0.04% 301
2025
Q4 		$794K Buy
15,596
+10,864
+230% +$556K 0.03% 349
2025
Q3 		$263K Sell
4,732
-75,877
-94% -$4.44M 0.01% 531
2025
Q2 		$5.56M Buy
80,609
+19,110
+31% +$1.3M 0.21% 114
2025
Q1 		$4.27M Buy
61,499
+57,812
+1,568% +$4.77M 0.18% 126
2024
Q4 		$317K Sell
3,687
-2,200
-37% -$238K 0.01% 446
2024
Q3 		$701K Buy
5,887
+68
+1% +$9.07K 0.03% 320
2024
Q2 		$831K Buy
5,819
+1,901
+49% +$252K 0.04% 300
2024
Q1 		$503K Buy
3,918
+1,019
+35% +$121K 0.02% 377
2023
Q4 		$300K Buy
2,899
+19
+0.7% +$1.88K 0.02% 434
2023
Q3 		$262K Sell
2,880
-136
-5% -$12K 0.02% 436
2023
Q2 		$244K Sell
3,016
-86
-3% -$7.03K 0.01% 447
2023
Q1 		$247K Buy
3,102
+146
+5% +$10.4K 0.02% 437
2022
Q4 		$200K Buy
+2,956
New +$173K 0.01% 453
2022
Q3 		– Sell
-3,244
Closed -$181K – 1185
2022
Q2 		$181K Buy
+3,244
New +$180K 0.01% 466

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM

Venture Visionary Partners's NVO Position: Q3 2026 in Review

Venture Visionary Partners reduced its Novo Nordisk (NVO) stake by 2.2% in Q3 2026, selling an estimated $25.3K and leaving 24,147 shares worth $915K. The position accounts for 0.02% of the portfolio, ranked #371.

Venture Visionary Partners first reported a position in NVO in Q2 2022 and has held it in 17 quarters since. The position peaked at $5.56M in Q2 2025. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Venture Visionary Partners held 24,147 shares of Novo Nordisk worth $915K as of Q3 2026.
  • Venture Visionary Partners sold 548 Novo Nordisk shares in Q3 2026, an estimated $25.3K.
  • Novo Nordisk made up 0.02% of Venture Visionary Partners's portfolio in Q3 2026, its #371 holding.
  • Venture Visionary Partners first reported a position in Novo Nordisk in Q2 2022 and has held it in 17 quarters since.
  • Venture Visionary Partners's Novo Nordisk position peaked at $5.56M in Q2 2025.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Venture Visionary Partners's 13F filing for Q3 2026, filed 7 Oct 2026.